Correlation between spot sign on dual-energy CT angiography and risk of hematoma enlargement in patients with hypertensive intracerebral hemorrhage
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 7
Abstract
"<b>Objective</b> To investigate the correlation between spot sign (SS) on energy computed tomography angiography (CTA) and the risk of hematoma enlargement (HE) in patients with hypertensive intracerebral hemorrhage (HICH). <b>Methods</b> A total of 115 patients with HICH admitted to Luzhou People's Hospital from January 2019 to September 2022 were included. All patients received conventional treatment for intracerebral hemorrhage, and during hospitalization, they were divided into enlarged group and non-enlarged group according to whether HE occurred. Demographic data, clinical characteristics, and laboratory examination data were analyzed, and multivariate logistic regression analysis was used to identify the factors associated with HE. <b>Results</b> Among the 115 patients with HICH, 41 had HE as the enlarged group, while 74 did not have HE as the non-enlarged group. Univariate analysis showed that there was no significant difference in general information between the two groups (P＞0.05); CTA SS score was higher in the enlarged group than that in the non-enlarged group, and the proportion of SS occurring in mixed arterial phase and delayed fusion phase, as well as irregular hematoma shape, was higher than those in the non-enlarged group. The volume of hematoma on initial CT was larger in the enlarged group than that in the non-enlarged group (P＜0.05). Multivariate logistic regression analysis showed that SS score (OR=23.703, 95%CI: 1.336-420.556), hematoma volume (OR=1.618, 95%CI: 1.090-2.399), occurrence of SS in mixed arterial phase (OR=2.198, 95%CI: 1.164-4.152), and delayed fusion phase (OR=2.553, 95%CI: 1.363-4.781) were independent risk factors for HE (P＜0.05). <b>Conclusion</b> The volume of hematoma on initial CT, CTA SS score, and occurrence of SS in mixed arterial phase and delayed fusion phase are related to the occurrence of HE in patients with HICH."
Authors and Affiliations
KANG Houle*, XIE Jian, XIAO Xuelu, DENG Hongyuan, HUANG Xueping
Keywords
Related Articles
- EP ID EP740732
- DOI 10.13429/j.cnki.cjcr.2024.07.019
- Views 45
- Downloads 1
Differentiation and treatment of vascular dementia from “spleen kidney - phlegm stasis”
Vascular dementia is an age.related neurodegenerative disease characterized by cerebral tissue hypoxiaresulting from cerebrovascular impairment. The development of this disease is closely associated with the spleen andki...
Efficacy of AngioJet thrombectomy with sequential low-dose urokinase thrombolysis in the treatment of acute iliofemoral venous thrombosis
Objective： To compare the clinical efficacy and safety of AngioJet thrombectomy with sequential low-dose urokinase thrombolysis versus catheter-directed thrombolysis(CDT) in the treatment of acute iliofemoral deep venou...
Correlation of gut microbiota with serum inflammatory index and 25-hydroxyvitamm D level in malnourished children
Objective To investigate the status of intestinal flora in malnourished children and its relationship with se.rum inflammatory cytokines and 25.hydroxyvitamin D［25 (OH) D］levels. Methods A total of 126 malnourished chi...
Predictive value of the simplified pulmonary embolism severity index combined with serum uric acid and neutrophil percentage in the short-term prognosis of lung cancer patients with acute pulmonary embolism
Objective：To explore the application and value of simplified pulmonary embolism severity index (sPESI) combined with serum uric acid (SUA) and neutrophil percentage (NEUT%) in the prediction of short-term prognosis of l...
Correlation of Hsa circ0016599 expression level with the efficacy of neoadjuvant chemotherapy in patients with triple-negative breast cancer
"Objective To analyze the expression of circular ribonucleic acid (circRNA) Hsa circ0016599 in patients with triple-negative breast cancer (TNBC) and its effect and predictive value for the efficacy of neoadjuvant chemot...